2024. RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases. 31, 1 (Mar. 2024), 394–406.